In 2004, researchers conducted a meta-analysis of 61 randomized controlled trials evaluating GLP-1 RAs, sodium-glucose co-transporter-2 inhibitors (SGLT2i), dipeptidyl peptidase 4 inhibitors (DPP-4i) and didnt find an increased risk of diabetic retinopathy events with GLP-1 RAs or any of the other classes of antihyperglycemic medications
Almandoz JP, Lingavy I, Morales J, Campos C
Unfortunately, the current trend is completely the opposite, with a steady increase in overweight and obesity affecting the youngest, putting them at very high risk of developing a veritable epidemic of cardiometabolic diseases in a few years (see our article on this subject)
Addisons disease: Addisons disease is an endocrine disorder due to adrenocortical insufficiency
If youre handling it well after another four weeks, your doctor might suggest increasing it to 1.0 mg
Lessen weight-related inflammation, allowing exercise to be more comfortable and accessible